Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 24.36 USD 1.29%
Market Cap: 3.3B USD

During the last 3 months Perrigo Company PLC insiders have not bought any shares, and sold 497.5k USD worth of shares. The stock price has dropped by 3% over this period (open performance analysis).

The last transaction was made on Dec 9, 2024 by Kindler Jeffrey B (Executive Vice President and President of the Consumer Self-Care International segment) , who sold 497.5k USD worth of PRGO shares.

Last Transactions:
Kindler Jeffrey B
Executive Vice President and President of the Consumer Self-Care International segment
$-497.5k
Doyle Katherine C.
Executive Vice President, General Counsel and Corporate Secretary
$-244.4k
Janish Ronald Craig
Chief Financial Officer
$-382.2k
Andersen Svend
Executive Vice President and President, Consumer Self-Care International
$+27.9k
Ives Alison
$+67.9k
Willis Robert
Chief Financial Officer
$+155.2k
Lockwood-Taylor Patrick
President and Chief Executive Officer
$+252.2k
Ives Alison
Senior Vice President, Chief Scientific Officer
$+40.8k
Willis Robert
Chief Financial Officer
$+172.1k
Ives Alison
Senior Vice President, Chief Scientific Officer
$+59.9k
Ives Alison
Senior Vice President, Chief Scientific Officer
$+59.9k
Bezerra Eduardo Guarita
Director
$+145.9k
Lockwood-Taylor Patrick
President and Chief Executive Officer
$+318.9k
Parker Geoffrey M.
Director
$+330.6k
Andersen Svend
Executive Vice President and President, Consumer Self-Care International
$+96.9k
Kessler Murray S
Executive Vice President and President, Consumer Self-Care International
$-7.1m
Farrington Thomas
Vice President, Corporate Communications and Public Affairs
$-125.3k
Dillard James E Iii
Director
$-321.3k
Janish Ronald Craig
Chief Financial Officer
$-166.1k
Parker Geoffrey M.
Director
$+190.3k
Quinn Grainne
Executive Vice President and President, Consumer Self-Care International
$-74.9k
Farrington Thomas
Vice President, Corporate Communications and Public Affairs
$-909.1k
Janish Ronald Craig
Chief Financial Officer
$-145.2k
Kingma Todd W
Chief Financial Officer
$+112.6k
Parker Geoffrey M.
Director
$+184.3k
Alford Bradley A
Executive Vice President and General Counsel
$+479.4k
Andersen Svend
Executive Vice President and President, Consumer Self-Care International
$+89.1k
Silcock Raymond
Executive Vice President and Chief Financial Officer
$+990.9k
Classon Rolf A
President
$+99.9k
Parker Geoffrey M.
Director
$+103.2k
Janish Ronald Craig
Chief Financial Officer
$-109.8k
Sorota Richard S
Executive Vice President, General Counsel and Corporate Secretary
$+326.7k
View All Transactions

During the last 3 months Perrigo Company PLC insiders have not bought any shares, and sold 497.5k USD worth of shares. The stock price has dropped by 3% over this period (open performance analysis).

The last transaction was made on Dec 9, 2024 by Kindler Jeffrey B (Executive Vice President and President of the Consumer Self-Care International segment) , who sold 497.5k USD worth of PRGO shares.

Sold
0-3
months
497.5k USD
1
3-6
months
626.7k USD
2
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
1
27.9k USD
9-12
months
3
516.1k USD

Perrigo Company PLC
Insider Trading Chart

Perrigo Company PLC
Last Insider Transactions

Global
Insiders Monitor

Perrigo Company PLC
Glance View

Market Cap
3.3B USD
Industry
Pharmaceuticals

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
65.19 USD
Undervaluation 63%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top